Interview: why the recently approved fecal microbiome product is causing a rumble
The news last week of the FDA approving Ferring Pharmaceuticals' first fecal microbiome product, Rebyota,…
December 5, 2022 - 5 minutes
Interview
LAG-3: The next big checkpoint inhibitor target
Since their first approval a decade ago, immune checkpoint inhibitors have been gaining momentum in…
November 29, 2022 - 7 minutes
Breaking barriers to gene therapies for childhood rare diseases
The majority of known rare genetic diseases affect children, and gene therapies could help them…
November 28, 2022 - 5 minutes
What recent mixed clinical results can teach about Alzheimer’s disease
2022 has provided mixed fortunes for companies aiming to slow Alzheimer’s disease. Ulrich Dauer, CEO…
November 23, 2022 - 7 minutes
How cardioids can usher in the next generation of drug discovery
The California-based Molecular Devices brings automated 3D cell culture and image analysis together with HeartBeat.bio’s…
November 18, 2022 - 6 minutes
MaaT Pharma: leading the charge in microbiome therapeutics
The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business…
November 14, 2022 - 5 minutes
In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus
AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the European Union (EU) for the…
November 14, 2022 - 9 minutes
AI could tackle pharmaceutical manufacturing bottlenecks
Artificial intelligence (AI) is making waves in the world of drug discovery. Rajiv Anand, founder…
November 7, 2022 - 6 minutes
AI and biobanks could open the way to longevity treatments
The development of longevity treatments is hampered by a lack of biomarkers and validated drug…
October 31, 2022 - 7 minutes
Migraines: a new vaccine frontier beyond infectious diseases
By bringing the efficiency and affordability of vaccines to chronic diseases such as migraines, U.S.…
October 28, 2022 - 7 minutes
CRISPR gene editing: a key tool for counteracting climate change
Monika Paulė, CEO and co-founder of the Lithuanian CRISPR developer Caszyme, explains how gene editing…
October 17, 2022 - 6 minutes
Boosting pharma’s falling productivity with AI in drug discovery
The pharmaceutical industry is struggling with mounting costs of drug development. Generate Biomedicines’ CEO, Michael…
October 12, 2022 - 5 minutes
